Functionality and Accuracy of the smART System in Real-Life ICU Settings

Aspiration Pneumonia Clinical Trial

Official title:

Functionality and Accuracy of the smART System in Real-Life ICU Settings

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT03198988
• Other study ID #: CLT3_SY_P001
• Status: Terminated
• Start date: October 26, 2017
• Est. completion date: April 28, 2020

Study information

• Verified date: July 2021
• Source: ART Medical Ltd.
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Total participants in the "Functionality and Accuracy of the smART System in Real-Life ICU Settings" are 10 participants - in the current Jefferson study site there were 8 participants and in the Sheba study site (identifier NCT03689985) there were 2 participants. This study is conducted in order to validate the functionality and accuracy of the smART™ System in a real-life ICU setting. The smART™ Feeding Tube System is a novel system with nasogastric tube developed by ART Medical (Healthcare) Ltd, based on sensor-lined tubes that transmit real-time information to an external console. The smART™ feeding tube is equipped with reflux sensors which alert when gastric contents regurgitating into the esophagus. In addition, the smART™ feeding tube is equipped with sensors designed to provide information about the location of the tube thus assisting in reducing the incident of misplacement during first positioning. The smART™ feeding tube is also automatically and in real-time stops feeding if the feeding tube moves out of position during ongoing use or detect gastric content in esophagus. Furthermore, smART™ Feeding Tube System can guide operator to correctly re-position the tube. Lastly the smART™ Feeding Tube System is equipped with an anti-reflux mechanism and automatic Gastric Residual Volume (GRV).

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 10
• Est. completion date: April 28, 2020
• Est. primary completion date: April 28, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Males and females 18 years or older
• Patient has already been admitted to ICU
• Patient requires enteral feeding
• Patients receiving Proton Pump Inhibitors (PPI) therapy
• Informed consent by independent physician and next of kin
• ICU ventilated patients

Exclusion Criteria:

• Patients with anomalies or diseases of the esophagus and or stomach.
• Patients with known sensitivities or allergies to any of the feeding tube materials
• Inability to place patient in semi-Fowler's position.
• Any clinically significant abnormality upon physical examination which may, in the opinion of the investigator, pose difficulty in inserting the feeding tube (e.g. cervical spine disorder)
• Pregnancy
• Recent abdominal surgery (less than 30 days)

Related Conditions & MeSH terms

• Aspiration Pneumonia
• Pneumonia, Aspiration

Intervention

Device:
• smART Feeding Tube System
Replacing generic feeding tube with smART Feeding Tube System.

Locations

Country	Name	City	State
United States	Thomas Jefferson University Hospital	Philadelphia	Pennsylvania

Sponsors (1)

Lead Sponsor	Collaborator
ART Medical Ltd.

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of Participants for Whom the System is Able to Accurately Guide and Ensure Correct Initial Feeding Tube Placement , Verified by X-ray		Enrollment visit
Primary	Number of Tube "Out of Position" Alerts During Ongoing Use	Any patient , in which the system alerted of tube out of position , the staff verified this according to the tube markings and if mispositioning occurred, this was documented the event in the CRF "out of position"	Enrollment day up to 7 days
Primary	Number of Automatic System Generated Feeding Stops in Response to Tube Displacement.	In order to prevent aspiration, the system software automatically pinches the feeding tube. Verification of the functionality of automatic feeding cessation when tube displacement is detected was done as part of the formal verification of the system	From insertion of feeding tube up to its removal , an average of 7 days.
Primary	Number of Major Reflux Event That Lead to Automatically Stops Feeding	Overfeeding is the intolerance of the stomach to feeding material that causes reflux. There are two types of reflux events as defined by the system; minor-reflux and massive-reflux. Both types of reflux events are detected by the level of fluids interacting with the sensors, the severity is defined by gastric content reaching above the lower esophageal sphincter (LES): Minor reflux is defined as gastric content that did not pass the balloon located in the center of the esophagus.; Massive reflux is defined as gastric content that reaches immediately above the balloon.	From insertion of feeding tube up to its removal , an average of 7 days.
Primary	Average Duration of Balloon Inflation in Response to a Reflux Episode.	Massive reflux of gastric content can aspirate into the lungs and cause pneumonia. The system detects the reflux event and will (according to an algorithm) stop the feeding and or inflate a balloon and evacuate gastric residuals from the stomach to lower the risk of aspiration.	From insertion of feeding tube up to its removal , an average of 7 days.
Secondary	Recording of Impedance Detected by the System and Correlation to Patient Positioning.	Positions changes were correlated to reflux events captured by the system console. Any position change of the patient was captured by the video camera located above the patient's bed.	From insertion of feeding tube up to its removal , an average of 7 days.
Secondary	Number of Participant With Change in Ventilator Associated Pneumonia (VAP) and/or Acute Respiratory Distress Syndrome (ARDS) as a Measure of Effectiveness in Reducing Aspiration of Gastric Contents	The first and the last X-ray images obtained for patients during the study were used to evaluate Ventilator Associated Pneumonia (VAP) and/or Acute respiratory distress syndrome (ARDS)	56 - 168 hours per patient